Business Description
Austar Lifesciences Ltd
ISIN : KYG0632L1023
Share Class Description:
AULSF: Shs Reg STotal Employee Number:
1,468Compare
Compare
Traded in other countries / regions
06118.Hong KongAULSF.USA IPO Date
2021-08-24Description
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.66 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 5.74 | |||||
Interest Coverage | 2.79 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.44 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -11.1 | |||||
3-Year EBITDA Growth Rate | -13.3 | |||||
3-Year EPS without NRI Growth Rate | -31.9 | |||||
3-Year Book Growth Rate | -3.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.36 | |||||
Quick Ratio | 1.12 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 72.77 | |||||
Days Sales Outstanding | 88.82 | |||||
Days Payable | 122.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 21.11 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.15 | |||||
Operating Margin % | 2.2 | |||||
Net Margin % | 2.2 | |||||
EBITDA Margin % | 3.93 | |||||
FCF Margin % | 6.72 | |||||
OCF Margin % | 8.65 | |||||
ROE % | 4.21 | |||||
ROA % | 1.64 | |||||
ROIC % | 1.79 | |||||
3-Year ROIIC % | 28.78 | |||||
ROC (Joel Greenblatt) % | 17.98 | |||||
ROCE % | 6.58 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 8.83 | |||||
PE Ratio without NRI | 10.15 | |||||
Shiller PE Ratio | 9.69 | |||||
Price-to-Owner-Earnings | 4.66 | |||||
PS Ratio | 0.21 | |||||
PB Ratio | 0.38 | |||||
Price-to-Tangible-Book | 0.4 | |||||
Price-to-Free-Cash-Flow | 3.09 | |||||
Price-to-Operating-Cash-Flow | 2.39 | |||||
EV-to-EBIT | 7.33 | |||||
EV-to-EBITDA | 7.33 | |||||
EV-to-Revenue | 0.29 | |||||
EV-to-FCF | 4.29 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Projected-FCF | 2 | |||||
Price-to-Median-PS-Value | 0.22 | |||||
Price-to-Graham-Number | 0.5 | |||||
| Price-to-Net-Current-Asset-Value | 1 | |||||
Earnings Yield (Greenblatt) % | 13.64 | |||||
FCF Yield % | 32.38 | |||||
Forward Rate of Return (Yacktman) % | -33.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AULSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Austar Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 215.53 | ||
| EPS (TTM) ($) | 0.01 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 71.43 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.002859 | ||
| 20-Day SMA ($) | 0.06 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.02 - 0.07 | ||
| Shares Outstanding (Mil) | 512.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Austar Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Austar Lifesciences Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Austar Lifesciences Ltd Frequently Asked Questions
What is Austar Lifesciences Ltd(AULSF)'s stock price today?
The current price of AULSF is $0.02. The 52 week high of AULSF is $0.07 and 52 week low is $0.02.
When is next earnings date of Austar Lifesciences Ltd(AULSF)?
The next earnings date of Austar Lifesciences Ltd(AULSF) is .
Does Austar Lifesciences Ltd(AULSF) pay dividends? If so, how much?
Austar Lifesciences Ltd(AULSF) does not pay dividend.
Guru Commentaries on OTCPK:AULSF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Austar Lifesciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers